Fecal microbiota transplantation: First case report in Chile and review;Trasplante de microbiota fecal: Primer caso reportado en Chile y revisión de la literatura

Revista Chilena de Infectologia

Volumn 31, Issue 4, 2014, Pages 477-482

  Espinoza, Ricardo ^a   Quera, Rodrigo ^a   Meyer, Lital ^a   Rivera, Daniela ^a  

^a CLÍNICA LAS CONDES   (Chile)

Author keywords

Bacteremia; Clostridium diffcile; Crohn s disease; Fecal transplantation; Infammatory bowel disease

Indexed keywords

ADVERSE EFFECTS; BACTEREMIA; BIOLOGICAL THERAPY; CASE REPORT; CHILE; CLOSTRIDIUM INFECTIONS; CROHN DISEASE; ESCHERICHIA COLI INFECTIONS; FECES; HUMAN; MALE; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; RECURRENT DISEASE; TRANSPLANTATION;

BACTEREMIA; BIOLOGICAL THERAPY; CHILE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROHN DISEASE; ESCHERICHIA COLI INFECTIONS; FECES; HUMANS; MALE; MICROBIOTA; MIDDLE AGED; RECURRENCE; TRANSPLANTATION;

EID: 84923376517     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: 10.4067/S0716-10182014000400016     Document Type: Article

References (34)

1. Surawicz C M, Brandt L J, Binion D G, Ananthakrishnan A N, Curry S R, Gilligan P H, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium diffcile infections. Am J Gastroenterol 2013; 108: 478-98.
2. Pérez M, Hurtado A I, Couto I, Gutiérrez J M, Seoane L, Suárez J M, et al. Abordaje multidisciplinario de la infección por Clostridium diffcile. Rev Chilena Infectol 2013; 30: 165-85.
3. Dupont H L. Diagnosis and management of Clostridium diffcile infection. Clin Gastroenterol Hepatol 2013; 11: 1216-23.
4. Aroniadis O C, Brandt L J. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol 2013; 29: 79-84.
5. Eiseman B, Silen W, Bascom G S, Kauvar A J. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44: 854-9.
6. Kassam Z, Lee C H, Yuan Y, Hunt R H. Fecal microbiota transplantation for Clostridium diffcile infection: systematic review and meta-analysis. Am J Gastroenterol 2013; 108: 500-8.
7. Petrof E O, Khoruts A. From stool transplants to next-generation microbiota therapeutics. Gastroenterology 2014; 146: 1573-82.
8. Konijeti G G, Sauk J, Shrime M G, Gupta M, Ananthakrishnan A N. Cost-effectiveness of competing strategies for management of recurrent Clostridium diffcile infection: a decision analysis. Clin Infect Dis 2014; 58: 1507-14.
9. Nagalingam N A, Lynch S V. Role of the microbiota in infammatory bowel diseases. Infamm Bowel Dis 2012; 18: 968-84.
10. Ohman L, Simrén M. Intestinal microbiota and its role in irritable bowel syndrome (IBS). Curr Gastroenterol Rep. 2013; 15: 323.
11. Everard A, Cani P D. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol 2013; 27: 73-83.
12. Smits L P, Bouter K E, de Vos W M, Borody T J, Nieuwdorp M. herapeutic potential of fecal microbiota transplantation. Gastroenterology 2013; 145: 946-53.
13. Khoruts A, Dicksved J, Jansson J K, Sadowsky M J. Changes in the composition of the human fecal microbiome after bacterioteraphy for recurrent Clostridium difccile-associated diarrhea. J Clin Gastroenterol 2010; 44: 354-60.
14. Brandt L J, Aroniadis O C, Mellow M, Kanatzar A, Kelly C, Park T, et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium diffcile infection. Am J Gastroenterol 2012; 107: 1079-87.
15. Kahn S A, Vachon A, Rodríguez D, Goeppinger S R, Surma B, Marks J, et al. Patients perceptions of fecal microbiota transplantation for ulcerative colitis. Infamm Bowel Dis. 2013; 19: 1506-13.
16. Brandt L J, Aroniadis O C. An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointest Endosc 2013; 78: 240-9.
17. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal E G, de Vo s WM, et al. Duodenal infusion of donor feces for recurrent Clostridium diffcile. N Engl J Med 2013; 368: 407-15.
18. Youngster I, Sauk J, Pindar C, Wilson R G, Kaplan J L, Smith M B, et al. Fecal microbiota transplant for relapsing Clostridium diffcile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis 2014; 58: 1515-22.
19. Persky S E, Brandt L J. Treatment of recurrent Clostridium diffcile-associated diarrhea by administration of donated stool directly through a colonoscope. Am J Gastroenterol 2000; 95: 3283-5.
20. Gough E, Shaikh H, Manges A R. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium diffcile infection. Clin Infect Dis 2011; 53: 994-1002.
21. Hamilton M J, Weingarden A R, Sadowsky M J, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium diffcile infection. Am J Gastroenterol 2012; 107: 761-7.
22. Issa M, Vijayapal A, Graham M B, Beaulieu D B, Otterson M F, Lundeen S, et al. Impact of Clostridium diffcile on infammatory bowel disease. Clin Gastroenterol Hepatol 2007; 5: 345-51.
23. Damman C J, Miller S I, Surawicz C M, Zisman T L. The microbiome and infammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Am J Gastroenterol 2012; 107: 1452-9.
24. Kunde S, Pham A, Bonczk S, Crumb T, Duba M, Conrad H Jr, et al. Safety, tolerability, and clinic response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr 2013; 56: 597-601.
25. Kump P K, Gröchening H P, Lackner S, Trajanoski S, Reicht G, Hoffmann K M, et al. Alteration of intestinal dysbiosis by fecal microbiota transplantation does no induce remission in patients with chronic active ulcerative colitis. Infamm Bowel Dis 2013; 19: 2155-65.
26. Angelberger S, Reinisch W, Makristathis A, Lichtenberger C, Dejaco C, Papay P, et al. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 2013; 108: 1620-30.
27. Duplessis C A, You D, Johnson M, Speziale A. Effcacious outcome employing fecal bacteriotherapy in severe Crohn’s colitis complicated by refractory Clostridium diffcile infection. Infection 2012; 40: 469-72.
28. Angelberger S, Lichtenberger C, Gratzer C. Fecal transplantation in patients with moderately to severely chronic active ulcerative colitis. J Crohn’s Colitis 2012; 6 (Suppl 1): S159.
29. Teshima C W, Dieleman L A, Meddings J B. Abnormal intestinal permeability in Crohn’s disease pathogenesis. Ann N Y Acad Sci. 2012; 1258: 159-65.
30. Benjamin J, Makharia G K, Ahuja V, Kalaivani M, Joshi Y K. Intestinal permeability and its association with the patient and disease characteristics in Crohn’s disease. World J Gastroenterol. 2008; 14: 1399-405.
31. De Leon L M, Watson J B, Kelly C R. Transient fare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium diffcile infection. Clin Gastroenterol Hepatol 2013; 11:1036-8.
32. Rubin D T. Curbing our enthusiasm for fecal transplantation in ulcerative colitis. Am J Gastroenterol. 2013; 108: 1631-3.
33. Kelly C R, Kunde S S, Khoruts A. Guidance on preparing an investigational new drug application for fecal microbiota transplantation. Clin Gastroenterol Hepatol 2014; 12: 283-8.
34. Quera R, Espinoza R, Estay C, Rivera D. Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn’s disease and recurrent Clostridium diffcile infection. J Crohn’s Colitis 2014; 8: 252-3.